Jodi Warman-Chardon

Dr. Jodi Warman Chardon - NMD4C investigator and steering committee member

Steering Committee Member

Clinician-Scientist, Director of the Ottawa Neuromuscular Centre, The Ottawa Hospital; Associate Scientist, OHRI; Scientist, CHEORI

Associate Professor of Neurology, Co-Director of the Centre for Neuromuscular Disease, University of Ottawa


NMD4C Involvement: Pillar 2: Clinical Research, Theme 5: Open Science

Email Jodi

Biography

Dr. Jodi Warman‑Chardon is a Clinician‑Scientist in the Department of Medicine at The Ottawa Hospital, the Ottawa Hospital Research Institute (OHRI) in Neurosciences and Clinical Epidemiology, and the Department of Genetics at the Children’s Hospital of Eastern Ontario, CHEO Research Institute. She is a Tier 2 Clinical Research Chair in Diagnosis and Discovery Pipeline for Patients with Genetic Neuromuscular Disease and an Associate Professor of Neurology at the University of Ottawa.

From 2014 to 2024, Dr. Warman‑Chardon served as co‑Director of the uOttawa Éric Poulin Centre for Neuromuscular Disease (CNMD), where she worked closely with Dr. Robin Parks to lead the Centre’s strategic development and support a community of more than 60 clinical and basic neuromuscular disease researchers. Her decade of leadership concluded with the appointment of new co‑Directors in November 2024. She also led the strategic development of, and now serves as Director of, the Ottawa Hospital Neuromuscular Centre, a diagnostic clinical research centre for patients with neuromuscular disorders.

Dr. Warman‑Chardon received her MD and completed her Neurology residency at the University of Ottawa, and earned her MSc from Queen’s University. She completed research and clinical fellowships in neuromuscular disorders at McGill University and a neurogenetics fellowship at the University of Ottawa. She is certified in electromyography (EMG) by the Canadian Society of Clinical Neurophysiologists.

Her clinical research focuses on improving genomic and imaging approaches for patients with inherited myopathies and neuromuscular disorders. She represents adult neuromuscular disorders as a member of the NMD4C Steering Committee and ensures that the next generation of neuromuscular scientists and clinicians is engaged in all aspects of the network’s work plan. She also contributes to genomics education for the network, leading efforts to engage trainees and early‑career researchers.


Recent Publications

Osman, H, Adamji, Z, Lintern, S, Smith, IC, Grant, A, Lessard, LER et al.. Counting the Cost: The Hidden Financial Realities of Neuromuscular Disease Through Patient and Family Perspectives. Health Expect. 2025.28 (6)e70529 PMID:41405177

Allen, MD, Carter, D, Warman-Chardon, J, Zwicker, J, Breiner, A. Case Series Assessing the Use of Levetiracetam for Gait Improvement in Primary Lateral Sclerosis. Can J Neurol Sci. 2025. 1-3 PMID:41332131

Lessard, LE, Bourque, DK, Bourque, PJ, Lochmüller, H, Machado, J, Del Gobbo, GF et al.. MT-ATP6 variant as a cause of adult-onset hereditary spastic paraparesis: A case report and literature review. J Neuromuscul Dis. 2025. 22143602251391068 PMID:41222985

Schellenberg, KL, Caspar-Bell, G, Ellis, C, Johnston, W, King, A, King, M et al.. Best practice recommendations for the clinical care of spinal bulbar muscular atrophy. CMAJ. 2025.197 (31)E987-E999 PMID:40983380

Grant, A, Smith, IC, Lessard, LER, Osman, H, Lochmuller, H, McMillan, HJ et al.. Financial Toxicity and Its Determinants in Individuals Living With Inherited and Acquired Neuromuscular Disorders: The BIND Study. Neurology. 2025.105 (5)e213982 PMID:40834345

See more on PubMed